Case Conference - ARDS and Hypoxemic Respiratory Failure in 34-Year-Old Male
34-year-old male transferred to MICU for hypoxemic respiratory failure with a history of asthma, recent respiratory symptoms, and suboptimal response to previous antibiotic treatment. Initial labs and imaging findings indicate a complex differential diagnosis involving multiple organ systems. Furthe
3 views • 24 slides
Critical Care Aspects of COVID-19 - Insights from Dr. Vikram Mukherjee, MD
Insights on critical care aspects of COVID-19, including clinical impressions, disease progression, treatment protocols for severe ARDS, management of cytokine release syndrome, and challenges faced in managing patients with COVID-19. Dr. Vikram Mukherjee shares observations and strategies based on
1 views • 30 slides
Effective Management of ARDS and Refractory Hypoxemia in COVID-19 Patients
Management of ARDS involves oxygen support and mechanical ventilation along with treating the underlying cause. Lung-protective ventilation strategies such as the OLA approach are recommended. Refractory hypoxemia in COVID-19 patients is challenging, often requiring adherence to ARDS guidelines. Mai
2 views • 28 slides
Understanding Mechanical Ventilation in Anesthesia Technology
Mechanical ventilation plays a crucial role in assisting patients with breathing difficulties by delivering oxygen and removing carbon dioxide. It involves two primary types: Negative Pressure Ventilation (NPV) and Positive Pressure Ventilation (PPV). NPV helps patients with conditions like chronic
0 views • 19 slides
COVID-19 Update: 3rd Week of March Overview
Key highlights from the 3rd week of March 2020 regarding COVID-19 include the situation in New Mexico, national statistics, global figures, the importance of ventilators in severe cases, transmission rates, and strategies for outbreak control. Information on cases, deaths, government actions, and me
0 views • 29 slides
BARDA Just Breathe ARDS Therapeutics Pitch Event Details
BARDA is hosting the Just Breathe ARDS Therapeutics Pitch Event to find host-directed therapeutic candidates for an upcoming ARDS clinical trial. The presentation covers submission guidelines, event basics, submission deadlines, evaluation criteria, and more. Drug sponsors are invited to participate
0 views • 23 slides
Airway Management in the NeuroICU: Importance and Strategies
Understanding the crucial role of airway management in the NeuroICU is essential for preventing secondary brain injury and addressing respiratory complications in neurologically-injured patients. This presentation covers the significance of airways, common issues, evaluation techniques, adjuncts, an
0 views • 45 slides
Management of Acute Respiratory Distress Syndrome: Case Study and Diagnostics
A 54-year-old woman post-laparotomy presents with respiratory distress and bilateral infiltrates on CXR. The case raises suspicion for Acute Respiratory Distress Syndrome (ARDS). Diagnostic criteria and potential investigations, such as CT pulmonary angiogram, thoracic USS, echocardiogram, bronchosc
0 views • 17 slides
Critical Care Aspects of COVID-19: Insights from Dr. Vikram Mukherjee, MD
Explore the critical care aspects of COVID-19 discussed by Dr. Vikram Mukherjee, MD, covering clinical characteristics, organ dysfunction, outcomes, inflammatory surge, X-ray findings, and more. Gain insights on the presentation, progression, and management of severe cases, including ARDS, cytokine
0 views • 21 slides
Methods for Quantifying Efficacy-Effectiveness Gap in Randomized Controlled Trials
This research discusses the quantification of the efficacy-effectiveness gap in randomized controlled trials (RCTs), particularly focusing on examples in Acute Respiratory Distress Syndrome (ARDS). It explores the challenges of RCTs, ethical considerations, and the use of observational data for caus
0 views • 8 slides
Just Breathe: ARDS Therapeutics Pitch Event Details
BARDA is hosting the "Just Breathe: An ARDS Therapeutics Pitch Event" to identify potential host-directed therapeutic candidates for an upcoming phase 2 ARDS clinical trial. The event will take place from July 24-28, 2023, with submission deadlines and evaluation criteria outlined. Drug sponsors are
0 views • 23 slides